Carregant...
Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
OBJECTIVE: This study evaluated the association of time in range (TIR) of 70–180 mg/dL (3.9–10 mmol/L) with the development or progression of retinopathy and development of microalbuminuria using the Diabetes Control and Complications Trial (DCCT) data set in order to validate the use of TIR as an o...
Guardat en:
| Publicat a: | Diabetes Care |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Diabetes Association
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6905478/ https://ncbi.nlm.nih.gov/pubmed/30352896 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc18-1444 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|